Human medicines
Ibandronic acid
The marketing authorization holder informed its customers in a letter dated April 18, 2013, that due to a technical defect during production, isolated…
Magnesiocard
The marketing authorization holder has informed its supplied customers and medical home pharmacies that a microbiological contamination has been…
Desloratadine
The distributor informed its supplied customers that during stability tests after a storage period of more than two years the specifications of the…
Tredaptive
The marketing authorization holder has informed its supplied customers that preliminary results from the HPS2-THRIVE study (Heart Protection Study…
Cefuroxim
The marketing authorization holder informed its supplied customers in a letter dated Dec. 20, 2012, that the batch would be replaced due to unusual…
Urokinase 50.000 I.E.
The distributor has informed its supplied customers that the above batch was intended for Germany or was placed on the market in Austria in German…
Iterium
In a letter dated November 29, 2012, the marketing authorization holder informed the physicians concerned that the shelf life of the physician samples…
EVICEL
The distributor informed its supplied customers in a letter dated November 14, 2012, that a deviation in the manufacturing process, which was…
Update: Fluad, Sandovac
Gelofusin
The marketing authorization holder informed its supplied customers in a letter dated October 24, 2012, that there is a possible pyrogen contamination…